| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.ATV.13.5.720 |
| P698 | PubMed publication ID | 8485124 |
| P50 | author | Philip W Connelly | Q59392339 |
| P2093 | author name string | G F Maguire | |
| J A Little | |||
| C Vezina | |||
| R A Hegele | |||
| D J Jenkins | |||
| L Tu | |||
| T S Wolever | |||
| P433 | issue | 5 | |
| P304 | page(s) | 720-728 | |
| P577 | publication date | 1993-05-01 | |
| P1433 | published in | Arteriosclerosis and thrombosis : a journal of vascular biology | Q27709770 |
| P1476 | title | Hepatic lipase deficiency. Clinical, biochemical, and molecular genetic characteristics | |
| P478 | volume | 13 |
| Q88352529 | A new enzyme-linked immunosorbent assay system for human serum hepatic triglyceride lipase |
| Q44168278 | A novel allele in the promoter of the hepatic lipase is associated with increased concentration of HDL-C and decreased promoter activity |
| Q22009153 | A novel endothelial-derived lipase that modulates HDL metabolism |
| Q36727383 | A novel method for measuring human lipoprotein lipase and hepatic lipase activities in postheparin plasma |
| Q72992423 | Absence of association between genetic variation in the LIPC gene promoter and plasma lipoproteins in three Canadian populations |
| Q37378483 | Association of variation in hepatic lipase activity with promoter variation in the hepatic lipase gene. The LOCAT Study Invsestigators |
| Q33688098 | Atheroprotective mechanisms of HDL. |
| Q36708030 | Biochemistry and pathophysiology of intravascular and intracellular lipolysis |
| Q44460221 | Characterization of a novel mutation causing hepatic lipase deficiency among French Canadians |
| Q47739431 | Characterization of two HDL subfractions and LpA-I, LpA-I:A-II distribution profiles and clinical characteristics of hyperalphalipoproteinemic subjects without cholesterol ester transfer protein deficiency |
| Q46020676 | Chinese hamster ovary cells expressing a cell surface-anchored form of hepatic lipase. Characterization of low density lipoprotein and chylomicron remnant uptake and selective uptake of high density lipoprotein-cholesteryl ester. |
| Q34155049 | Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport |
| Q31132390 | Comparative analyses of lipoprotein lipase, hepatic lipase, and endothelial lipase, and their binding properties with known inhibitors |
| Q33833805 | Decreases in the serum VLDL-TG/non-VLDL-TG ratio from early stages of chronic hepatitis C: alterations in TG-rich lipoprotein levels |
| Q44021015 | Deficiency in sPLA(2) does not affect HDL levels or atherosclerosis in mice |
| Q73575756 | Detection of missense mutations in the genes for lipoprotein lipase and hepatic triglyceride lipase in patients with dyslipidemia undergoing coronary angiography |
| Q74057286 | Dietary fat clearance in type V hyperlipoproteinaemia secondary to a rare variant of human apolipoprotein E: the apolipoprotein E3 (Arg 136-->Ser) |
| Q70785781 | Electrophoretic screening for human apolipoprotein C-II variants: repeated identification of apolipoprotein C-II(K19T) |
| Q34830395 | Endothelial lipase: direct evidence for a role in HDL metabolism |
| Q44919539 | Evidence that hepatic lipase deficiency in humans is not associated with proatherogenic changes in HDL composition and metabolism |
| Q33858537 | Expression of human hepatic lipase negatively impacts apolipoprotein A-I production in primary hepatocytes from Lipc-null mice. |
| Q40674487 | Fatty acids liberated from high-density lipoprotein phospholipids by endothelial-derived lipase are incorporated into lipids in HepG2 cells |
| Q41465066 | Gene therapy for atherosclerosis |
| Q34107177 | Gene therapy for dyslipidemia: clinical prospects |
| Q33877037 | Genes influencing HDL metabolism: new perspectives and implications for atherosclerosis prevention |
| Q33993060 | Genetic causes of high and low serum HDL-cholesterol |
| Q34651427 | Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol |
| Q38630971 | HDL and atherosclerotic cardiovascular disease: genetic insights into complex biology |
| Q46866176 | HDL--is it too big to fail? |
| Q47962063 | Hepatic lipase affects both HDL and ApoB-containing lipoprotein levels in the mouse |
| Q35086127 | Hepatic lipase and dyslipidemia: interactions among genetic variants, obesity, gender, and diet |
| Q34756336 | Hepatic lipase deficiency. |
| Q37351772 | Hepatic lipase gene therapy in hepatic lipase-deficient mice. Adenovirus-mediated replacement of a lipolytic enzyme to the vascular endothelium |
| Q28581153 | Hepatic lipase is localized at the parenchymal cell microvilli in rat liver |
| Q77714408 | Hepatic lipase mediates an increase in selective uptake of high-density lipoprotein-associated cholesteryl esters by human Hep 3B hepatoma cells in culture |
| Q38303206 | Hepatic lipase promoter activity is reduced by the C-480T and G-216A substitutions present in the common LIPC gene variant, and is increased by Upstream Stimulatory Factor |
| Q28626701 | Hepatic lipase: high-level expression and subunit structure determination |
| Q73111097 | Heterozygous hepatic lipase deficiency, due to two missense mutations R186H and L334F, in the HL gene |
| Q45870343 | High-density lipoprotein metabolism and reverse cholesterol transport: strategies for raising HDL cholesterol |
| Q34107511 | High-density lipoprotein metabolism: molecular targets for new therapies for atherosclerosis |
| Q39442094 | High-density lipoprotein subpopulation profiles in lipoprotein lipase and hepatic lipase deficiency. |
| Q34990624 | High-density lipoproteins and atherosclerosis |
| Q57428565 | Higher order lipase gene association with plasma triglycerides |
| Q35062402 | Hugh sinclair lecture: the regulation and remodelling of HDL by plasma factors |
| Q35824669 | Human ApoA-II inhibits the hydrolysis of HDL triglyceride and the decrease of HDL size induced by hypertriglyceridemia and cholesteryl ester transfer protein in transgenic mice |
| Q36503521 | Human genetics of variation in high-density lipoprotein cholesterol |
| Q41168114 | Human hepatic lipase subunit structure determination |
| Q38235600 | Hyperlipoproteinemia type 3: the forgotten phenotype |
| Q42989672 | Identification of a heparin-releasable hepatic lipase binding protein from rat liver |
| Q51566083 | In vitro production of beta-very low density lipoproteins and small, dense low density lipoproteins in mildly hypertriglyceridemic plasma: role of activities of lecithin:cholester acyltransferase, cholesterylester transfer proteins and lipoprotein l |
| Q40579349 | Insulin and lipoprotein metabolism with special reference to the diabetic state |
| Q46452061 | Interactions between hepatic lipase and apolipoprotein E gene polymorphisms affect serum lipid profiles of healthy Canadian adults |
| Q50299754 | LIPC dimer hydrolyses TAG to DAG and FA |
| Q35784094 | Lipase maturation factor 1: a lipase chaperone involved in lipid metabolism |
| Q34594298 | Lipases and HDL metabolism |
| Q36493893 | Lipidomic analyses of female mice lacking hepatic lipase and endothelial lipase indicate selective modulation of plasma lipid species. |
| Q33904125 | Mechanisms of lipase maturation |
| Q34040090 | Molecular mechanisms, lipoprotein abnormalities and atherogenicity of hyperalphalipoproteinemia |
| Q28363810 | Monogenic dyslipidemias: window on determinants of plasma lipoprotein metabolism |
| Q34707630 | No prescription for despair |
| Q35743918 | Overexpression of hepatic lipase in transgenic rabbits leads to a marked reduction of plasma high density lipoproteins and intermediate density lipoproteins |
| Q47121697 | Polygenic determinants in extremes of high-density lipoprotein cholesterol |
| Q43913020 | Polymorphism of HL +1075C, but not -480T, is associated with plasma high density lipoprotein cholesterol and apolipoprotein AI in men of a Chinese population |
| Q33577888 | Polymorphisms in the hepatic lipase gene affect plasma HDL-cholesterol levels in a Turkish population |
| Q35576667 | Positive association of the hepatic lipase gene polymorphism c.514C > T with estrogen replacement therapy response |
| Q90464954 | Rare dyslipidaemias, from phenotype to genotype to management: a European Atherosclerosis Society task force consensus statement |
| Q33597635 | Receptor-mediated mechanisms of lipoprotein remnant catabolism |
| Q35249345 | Recessive inheritance of obesity in familial non-insulin-dependent diabetes mellitus, and lack of linkage to nine candidate genes |
| Q44774939 | Reciprocal hemizygosity analysis of mouse hepatic lipase reveals influence on obesity |
| Q35212558 | Regulation of reverse cholesterol transport and clinical implications |
| Q36300834 | Reverse cholesterol transport and cholesterol efflux in atherosclerosis |
| Q40875893 | Reverse cholesterol transport--a review of the process and its clinical implications |
| Q33652033 | Role of fibrates in the management of hypertriglyceridemia |
| Q34901554 | Role of hepatic lipase and endothelial lipase in high-density lipoprotein-mediated reverse cholesterol transport |
| Q71371400 | Sandwich immunoassay for measurement of human hepatic lipase |
| Q39614897 | Secretion of triacylglycerol-poor VLDL particles from McA-RH7777 cells expressing human hepatic lipase |
| Q45005915 | Severe hypoalphalipoproteinemia in mice expressing human hepatic lipase deficient in binding to heparan sulfate proteoglycan. |
| Q51565747 | The atherogenic significance of an elevated plasma triglyceride level. |
| Q40964824 | The genetic determinants of plasma cholesterol and response to diet |
| Q37167521 | The independent relationship between triglycerides and coronary heart disease. |
| Q33746682 | The role of hepatic lipase in lipoprotein metabolism. |
| Q53528346 | The two novel CETP mutations Gln87X and Gln165X in a compound heterozygous state are associated with marked hyperalphalipoproteinemia and absence of significant coronary artery disease. |
| Q35824568 | Variation at the hepatic lipase and apolipoprotein AI/CIII/AIV loci is a major cause of genetically determined variation in plasma HDL cholesterol levels |
| Q24802147 | Genetic study of common variants at the Apo E, Apo AI, Apo CIII, Apo B, lipoprotein lipase (LPL) and hepatic lipase (LIPC) genes and coronary artery disease (CAD): variation in LIPC gene associates with clinical outcomes in patients with established |
Search more.